Patients with SLE had an increased proportion of double negative CD27-IgD- B cells among peripheral CD19+ B cells (16 ± 5.8%, mean ± SD) compared to healthy individuals (7.8 ± 5.8%, p<0.01) (Fig 1B). The gene discussed is CD27; the disease is systemic lupus erythematosus.